Enhancing Pharmaceutical Synthesis with High-Purity Chiral Piperazines
The pharmaceutical industry continually strives for greater precision and efficacy in drug development, a pursuit that heavily relies on the availability of highly specific and pure chemical intermediates. Among these, chiral piperazines play a vital role, serving as fundamental building blocks for a vast array of Active Pharmaceutical Ingredients (APIs). This article delves into the significance of high-purity chiral piperazines, exemplified by (S)-1-N-Boc-2-Methylpiperazine (CAS 169447-70-5), and discusses how R&D scientists and procurement managers can best secure these critical materials.
(S)-1-N-Boc-2-Methylpiperazine, with its distinct chiral center and protected amine functionality, is a highly sought-after intermediate. Its molecular formula C10H20N2O2 and a molecular weight of 200.3 make it amenable to various organic transformations. The compound’s specific rotation of +68.5° in chloroform is a key indicator of its enantiomeric purity, a characteristic that is often crucial for the biological activity and safety profile of the final pharmaceutical product. As a white powder with a melting point in the range of 34-36°C, it presents convenient handling properties for laboratory and industrial use. When sourcing this chemical, seeking a manufacturer in China known for stringent quality control ensures you receive material that meets these precise specifications.
For R&D scientists, integrating intermediates like (S)-1-N-Boc-2-Methylpiperazine into synthetic routes requires confidence in the material's consistency and reliability. This often translates to a preference for suppliers who can provide comprehensive technical documentation, including detailed COAs that confirm purity and stereochemical integrity. Furthermore, the ability to obtain samples for preliminary testing is crucial for validating the intermediate’s performance in specific reactions. Procurement managers, on the other hand, focus on securing a stable supply chain and competitive pricing. Inquiring about bulk discounts, payment terms, and delivery schedules is standard practice when planning large-scale production needs. If you are looking to buy (S)-1-N-Boc-2-Methylpiperazine, finding a supplier with substantial production capacity and years of export experience is highly advisable.
The market offers various options, but partnering with a dedicated supplier who understands the intricacies of pharmaceutical intermediates can streamline the procurement process. This includes clear communication regarding product specifications, customization options, and timely order fulfillment. For example, a buyer might search for “high purity chiral piperazine derivative price” or “C10H20N2O2 supplier quote” to compare offerings. Establishing a relationship with a supplier that has a proven history of reliability, potentially indicated by high repeat buyer rates or collaborations with major industry players, can provide a significant strategic advantage.
In conclusion, the effective integration of chiral piperazines like (S)-1-N-Boc-2-Methylpiperazine into pharmaceutical synthesis relies on careful selection of suppliers. By prioritizing purity, verifiable specifications, consistent supply, and responsive customer service, R&D professionals and procurement teams can ensure they are equipped with the high-quality materials needed to drive innovation and bring life-saving medicines to market. When you need to purchase CAS 169447-70-5, look for partners committed to excellence.
Perspectives & Insights
Molecule Vision 7
“Inquiring about bulk discounts, payment terms, and delivery schedules is standard practice when planning large-scale production needs.”
Alpha Origin 24
“If you are looking to buy (S)-1-N-Boc-2-Methylpiperazine, finding a supplier with substantial production capacity and years of export experience is highly advisable.”
Future Analyst X
“The market offers various options, but partnering with a dedicated supplier who understands the intricacies of pharmaceutical intermediates can streamline the procurement process.”